Disposition of 12569 shares by Paul Badawi of Sight Sciences at 6.417 subject to Rule 16b-3
SGHT Stock | USD 3.87 0.17 4.59% |
Slightly above 55% of Sight Sciences' private investors are presently thinking to get in. The analysis of overall sentiment of trading Sight Sciences stock suggests that some investors are interested at this time. Sight Sciences' investing sentiment can be driven by a variety of factors including economic data, Sight Sciences' earnings reports, geopolitical events, and overall market trends.
Sight |
Filed transaction by Sight Sciences Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Sight Sciences Fundamental Analysis
We analyze Sight Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sight Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sight Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Sight Sciences is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Sight Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sight Sciences stock to make a market-neutral strategy. Peer analysis of Sight Sciences could also be used in its relative valuation, which is a method of valuing Sight Sciences by comparing valuation metrics with similar companies.
Peers
Sight Sciences Related Equities
LUNG | Pulmonx Corp | 3.90 | ||||
RPID | Rapid Micro | 1.94 | ||||
SIBN | Si Bone | 0.90 | ||||
NPCE | Neuropace | 0.80 | ||||
AORT | Artivion | 0.61 | ||||
CVRX | CVRx | 0.60 | ||||
OFIX | Orthofix Medical | 0.32 | ||||
KIDS | Orthopediatrics Corp | 0.30 | ||||
CNMD | CONMED | 0.48 | ||||
ANIK | Anika Therapeutics | 0.51 | ||||
TCMD | Tactile Systems | 0.65 | ||||
FNA | Paragon 28 | 1.76 | ||||
VREX | Varex Imaging | 1.87 | ||||
AVNS | Avanos Medical | 2.22 |
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.